Impaired Fasting Glucose Clinical Trial
Official title:
The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population
NCT number | NCT02119325 |
Other study ID # | 202180 |
Secondary ID | RH01899 |
Status | Completed |
Phase | N/A |
First received | April 17, 2014 |
Last updated | May 11, 2015 |
Start date | September 2013 |
Verified date | April 2015 |
Source | GlaxoSmithKline |
Contact | n/a |
Is FDA regulated | No |
Health authority | India: Independent Ethics Committee |
Study type | Interventional |
The primary aim of this study is to evaluate the effect of a fibre rich health food drink on the post prandial glucose and triglyceride peak in healthy overweight adults with impaired fasting glucose (IFG). The study is randomised, stratified, double blind, two treatments, two period cross over study.
Status | Completed |
Enrollment | 96 |
Est. completion date | |
Est. primary completion date | October 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Healthy overweight male and female participants - Age 18-75 years - BMI =25<35 Kg/m2 Exclusion Criteria: - Pregnancy/breast-feeding - Allergy/Intolerance - Anaemic participants: Hb <10g/dL - Diabetic participants: fasting blood glucose >125 mg/dL - Serum Aspartate Transaminase, Alkaline Phosphatase and Serum albumin level 3 times the upper limit of normal range - Participants on other medications (lipid lowering drugs, oral hypoglycemics) |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)
Country | Name | City | State |
---|---|---|---|
India | Lambda Therapeutic Research Ltd | Ahmedabad | Gujarat |
Lead Sponsor | Collaborator |
---|---|
GlaxoSmithKline |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cmax for Glucose in IFG Status Participants | To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults with impaired fasting glucose (IFG) | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Primary | Cmax for Triglyceride in IFG Status Participants | To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Cmax for Glucose in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | AUC for Glucose in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for glucose in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Tmax for Glucose in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on the time when maximum post prandial concentration is reached (Tmax) of blood glucose in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Cmax for Triglyceride in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | AUC for Triglycerides in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for triglycerides in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Tmax for Triglycerides in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on Tmax of triglycerides in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Cmax for RLP Cholesterol in IFG Status Participants | To evaluate the effect of fibre rich health food drink on post prandial Remnant Lipoprotein Cholesterol (RLP Cholesterol) peak (Cmax) in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | AUC for RLP Cholesterol in IFG Status Participants | To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Tmax for RLP Cholesterol in IFG Status Participants | To evaluate the effect of fibre rich health food drink on Tmax for RLP Cholesterol in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Cmax for RLP Cholesterol in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on post prandial RLP Cholesterol peak (Cmax) in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | AUC for RLP Cholesterol in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Tmax for RLP Cholesterol in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on Tmax of RLP Cholesterol in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Cmax for Insulin in IFG Status Participants | To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | AUC for Insulin in IFG Status Participants | To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Tmax for Insulin in IFG Status Participants | To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults with IFG | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Cmax for Insulin in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | AUC for Insulin in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Secondary | Tmax for Insulin in Overweight Healthy Participants | To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults | Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01488279 -
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
|
N/A | |
Completed |
NCT00990184 -
Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)
|
Phase 3 | |
Completed |
NCT00573781 -
Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism
|
Phase 2 | |
Terminated |
NCT01204216 -
Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c
|
N/A | |
Completed |
NCT02700334 -
Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
|
Phase 4 | |
Active, not recruiting |
NCT01933529 -
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
|
Phase 2 | |
Completed |
NCT01729078 -
Dietary Interventions in Prediabetes
|
N/A | |
Completed |
NCT02896010 -
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
|
N/A | |
Completed |
NCT03650023 -
A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT
|
N/A | |
Completed |
NCT02542033 -
Glycemic Response to Low Sugar Apple Juice
|
N/A | |
Completed |
NCT01375660 -
D Vitamin Intervention in VA
|
N/A | |
Active, not recruiting |
NCT03029390 -
Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes
|
Phase 4 | |
Completed |
NCT00259168 -
Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
|
Phase 4 | |
Completed |
NCT01807351 -
Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting
|
N/A | |
Completed |
NCT01386645 -
Effect of Dietary Glycemic Index on Beta-cell Function
|
N/A | |
Completed |
NCT05544825 -
Ice Plant (Mesembryanthemum Crystallinum) Extract in Patients With Impaired Fasting Glucose
|
N/A | |
Withdrawn |
NCT03315663 -
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes - Main Study
|
N/A | |
Completed |
NCT01895387 -
Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes
|
N/A | |
Completed |
NCT03419702 -
Almonds and Health Effects on Metabolism, Vascular Function and Cognition
|
N/A | |
Completed |
NCT01549600 -
Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose
|
N/A |